z-logo
open-access-imgOpen Access
Cardiac amyloidosis presenting with coronary artery embolization
Author(s) -
Christos Papageorgiou,
Eleftheria P. Tsagalou,
Ioannis G. Baraboutis,
Konstantinos Tampakis,
Efstathios Kastritis
Publication year - 2021
Publication title -
reviews in cardiovascular medicine
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.555
H-Index - 39
eISSN - 2153-8174
pISSN - 1530-6550
DOI - 10.31083/j.rcm2203094
Subject(s) - medicine , cardiac amyloidosis , cardiology , embolization , myocardial infarction , amyloidosis , radiology , coronary artery disease , heart failure
Amyloid light-chain (AL) amyloidosis is a multisystemic disease. Among its clinical manifestations, vein and arterial thromboembolic events are included. We report the unusual case of a 57-year-old female patient with AL amyloidosis presenting with an ST segment elevation myocardial infarction due to coronary artery embolization (CE). The patient reported a history of exertional dyspnoea along with episodes of haemoptysis for the last few months. Her coronary angiography demonstrated embolization of the distal segment of the left anterior descending artery. The main findings of her cardiac ultrasound included concentric left ventricular hypertrophy, mildly impaired left ventricular systolic function, left atrium enlargement and a restrictive-like filling pattern, while her chest computed tomography (CT) demonstrated bilateral pleural effusions. Cardiac magnetic resonance imaging that was performed afterwards, indicated areas of microvascular infarction, a small apex infarct and findings compatible with possible amyloidosis, a diagnosis that was confirmed later by fat tissue biopsy. Patient was referred for an oncology consultation, started therapy with direct oral anticoagulants, angiotensin converting enzyme inhibitor, statins and anti-plasma cell therapy. She has been improving since then and has been free of cardiovascular events for a follow-up period of 12 months. Cardiologists ought to be aware of amyloidosis as a rare but possible cause of coronary embolization, while close collaboration with oncologists is required for the establishment of the correct diagnosis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here